Evaluation of the Effect of Wet Cupping (Hijama) on Primary Fibromyalgia
Recruiting · NCT06320262 · Interventional (participants receive a specific treatment) · Lead sponsor: Rasmia Elgohary
View the official record on ClinicalTrials.gov →Interventions studied
Wet cupping therapy (WCT)
What this trial is about
Fibromyalgia has become one of the most prevalent chronic pain conditions that impair quality of life. Wet cupping has gained increasing popularity in treating painful conditions. This study aims to investigate the effectiveness of wet cupping therapy combined with home-based exercise compared to home-based exercise alone in improving patients diagnosed with primary fibromyalgia syndrome.
Who can take part
Age range
18 Years to 55 Years
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Adult patients aged 18-55 years.
- Female individuals to avoid the gender confounding factor.
- Clinical diagnosis of primary fibromyalgia according to the 2016 American College of Rheumatology (ACR) updated diagnostic criteria.
- Moderate pain intensity of ≥ 45 mm or higher on a visual analog scale (VAS).
- No use of skeletal muscle relaxants, antidepressants, antiepileptic drugs, corticosteroids, benzodiazepines, and tramadol within a year before the screening visit.
Exclusion criteria
- Underlying rheumatic, malignant, metabolic, hematological, or neurological disorders.
- Patients with bleeding disorders or receiving anticoagulants.
- Previous use, within a year, or current use of skeletal muscle relaxants, antidepressants, antiepileptic drugs, corticosteroids, benzodiazepines, or tramadol
- Patients with BMI ≤ 18 or ≥ 35.
- Pregnant or lactating women.
- Patients with severe anemia.
Where it is running
1 location listed.
- Rheumatology and Immunology out patient clinic, Internal Medicine Department, Cairo University - Cairo, Egypt